The Techniques of Speech Therapy Management of Voice and Speech Disorders in Parkinson’s Disease
Article Sidebar
Published:
Jun 16, 2025
Keywords:
Speech theray, Parkinson disease, voice and speech disorders
Main Article Content
Abstract
To date, there is no reliable and scientifically valid study providing evidence of the effectiveness or lack thereof of speech therapy in speech disorders of Parkinson disease (PD), due to sample sizes that are too small. However, starting from the 1980s, objective measures (acoustic and video) and results from self-assessment scales concluding the immediate and medium-term effectiveness (3 to 12 months) of rehabilitation have made it possible to determine principles of rehabilitation. Unfortunately in Algeria, a minority of speech therapists treat voice and speech disorders related to Parkinson's disease. Through a bibliographic research on the website of the Ministry of Health of the United States of America, we were able to identify the main methods currently adopted by speech therapists to manage voice and speech disorders in Parkinson's patients that we will present in detail in this study.
Article Details
How to Cite
Kaddour , A. (2025). The Techniques of Speech Therapy Management of Voice and Speech Disorders in Parkinson’s Disease. Social and Human Science Studies, 14(2), 919 - 926. https://doi.org/10.46315/1714-014-002-061
Section
Articles
Copyright Notice
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
This allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal[cite: 2, 11].
The journal allows authors to deposit the Version of Record (published version) in an institutional or other repository of their choice without any embargo period.
This journal is compliant with DOAJ standards for author copyright retention and open licensing (CC BY 4.0).
References
1. Ascherio, A., & Schwarzschild, M. A.(2016). The epidemiology of Parkinson's disease: risk factors and prevention. The Lancet. Neurology*, 15(12), 1257–1272. https://doi.org/10.1016/S1474-4422(16)30230-7.
2. Armstrong, M. J., & Okun, M. S. (2020). Diagnosis and Treatment of Parkinson Disease: A Review. JAMA, 323(6), 548–560. https://doi.org/10.1001/jama.2019.22360.
3. Beitz, J. M. (2014). Parkinson's disease: a review. Frontiers in bioscience (Scholar edition), 6(1), 65–74. https://doi.org/10.2741/s415.
4. Darley, F. L., Aronson, A. E., & Brown, J. R. (1969). Differential diagnostic patterns of dysarthria. Journal of speech and hearing research*, 12(2), 246–269. https://doi.org/10.1044/jshr.1202.246.
5. Dashtipour, K., Tafreshi, A., Lee, J., & Crawley, B. (2018). Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches. Neurodegenerative disease management, 8(5), 337–348. https://doi.org/10.2217/nmt-2018-0021.
6. Deane, K. H., Whurr, R., Playford, E. D., Ben-Shlomo, Y., & Clarke, C. E. (2001). Speech and language therapy for dysarthria in Parkinson's disease. The Cochrane database of systematic reviews, (2), CD002812. https://doi.org/10.1002/14651858.CD002812.
7. Fox, C., Ebersbach, G., Ramig, L., & Sapir, S. (2012). LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease. Parkinsons Dis. , 2012, 391946. https://doi:10.1155/2012/391946.
8. Goldman, J. G., Volpe, D., Ellis, T. D., Hirsch, M. A., Johnson, J., Wood, J., Aragon, A., Biundo, R., Di Rocco, A., Kasman, G. S., Iansek, R., Miyasaki, J., McConvey, V. M., Munneke, M., Pinto, S., St Clair, K. A., Toledo, S., York, M. K., Todaro, R., Yarab, N., & Wallock, K. (2024). Delivering Multidisciplinary Rehabilitation Care in Parkinson's Disease: An International Consensus Statement. Journal of Parkinson's disease, 14(1), 135–166. https://doi.org/10.3233/JPD-230117.
9. Kaddour, A. (2018). La prise en charge de la dysarthrie par la méthode LSVT®. Grin Verlag Munich, ISBN : 9783668646414.
10. Le Huche, F., & Allali, A. (1989). La voix- Tome 4 : thérapeutique des troubles vocaux. Phoniatrie (3ème édition, Vol. Tome 4). Issy Les Moulineaux: Elsevier Masson.
11. Machado Sotomayor, M. J., Arufe-Giráldez, V., Ruíz-Rico, G., & Navarro-Patón, R. (2021). Music Therapy and Parkinson's Disease: A Systematic Review from 2015-2020. *International journal of environmental research and public health, 18(21), 11618. https://doi.org/10.3390/ijerph182111618.
12. Ma, A., Lau, K. K., & Thyagarajan, D. (2020). Voice changes in Parkinson's disease: What are they telling us?. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia, 72, 1–7. https://doi.org/10.1016/j.jocn.2019.12.029.
13. Pinto, S., Cardoso, R., Atkinson-Clement, C., Guimarães, I., Sadat, J., Santos, H., Mercier, C., Carvalho, J., Cuartero, M. C., Oliveira, P., Welby, P., Frota, S., Cavazzini, E., Vigário, M., Letanneux, A., Cruz, M., Brulefert, C., Desmoulins, M., Martins, I. P., Rothe-Neves, R., & Ferreira, J. J. (2024). Do Acoustic Characteristics of Dysarthria in People With Parkinson's Disease Differ Across Languages?. Journal of speech, language, and hearing research: JSLHR, 67(9), 2822–2841. https://doi.org/10.1044/2024_JSLHR-23-00525.
14. Ramig, L., Halpern, A., Spielman, J., Fox, C., & Freeman, K. (2018). Speech treatment in Parkinson's disease: Randomized controlled trial (RCT). Movement disorders: official journal of the Movement Disorder Society, 33(11), 1777–1791. https://doi.org/10.1002/mds.27460.
15. Radhakrishnan, N. N.(2022). Nasal Resistance (NR) Technique: A Novel Approach to Improve Glottal Adduction. J Voice, 36(1), 91-97. https://doi:10.1016/j.jvoice.2020.04.020.
16. Selikhova, M., Tripoliti, E., Fedoryshyn, L., Matvienko, Y., Stanetska, H., Boychuk, M., Komnatska, I., Lees, A. J., & Sanotsky, Y. (2016). Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse. Clinical neurology and neurosurgery, 147, 71–77. https://doi.org/10.1016/j.clineuro.2016.05.027.
17. Simon, D. K., Tanner, C. M., & Brundin, P. (2020). Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in geriatric medicine, 36(1), 1–12. https://doi.org/10.1016/j.cger.2019.08.002.
18. Spielman, J., Mahler, L., Halpern, A., Gilley, P., Klepitskaya, O., & Ramig, L. (2011). Intensive voice treatment (LSVT®LOUD) for Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. Journal of Communication Disorders, 44(6), 688–700.
19. Theodoros, D., & Anderson, A. (2024). Speech therapy for people with Parkinson's disease. BMJ (Clinical research ed.), 386, q1254. https://doi.org/10.1136/bmj.q1254.
20. Pinto, S., Ozsancak, C., Tripoliti, E., Thobois, S., Limousin-Dowsey, P., & Auzou, P. (2004). Treatments for dysarthria in Parkinson's disease. The Lancet. Neurology, 3(9), 547–556. https://doi.org/10.1016/S1474-4422(04)00854-3.
2. Armstrong, M. J., & Okun, M. S. (2020). Diagnosis and Treatment of Parkinson Disease: A Review. JAMA, 323(6), 548–560. https://doi.org/10.1001/jama.2019.22360.
3. Beitz, J. M. (2014). Parkinson's disease: a review. Frontiers in bioscience (Scholar edition), 6(1), 65–74. https://doi.org/10.2741/s415.
4. Darley, F. L., Aronson, A. E., & Brown, J. R. (1969). Differential diagnostic patterns of dysarthria. Journal of speech and hearing research*, 12(2), 246–269. https://doi.org/10.1044/jshr.1202.246.
5. Dashtipour, K., Tafreshi, A., Lee, J., & Crawley, B. (2018). Speech disorders in Parkinson's disease: pathophysiology, medical management and surgical approaches. Neurodegenerative disease management, 8(5), 337–348. https://doi.org/10.2217/nmt-2018-0021.
6. Deane, K. H., Whurr, R., Playford, E. D., Ben-Shlomo, Y., & Clarke, C. E. (2001). Speech and language therapy for dysarthria in Parkinson's disease. The Cochrane database of systematic reviews, (2), CD002812. https://doi.org/10.1002/14651858.CD002812.
7. Fox, C., Ebersbach, G., Ramig, L., & Sapir, S. (2012). LSVT LOUD and LSVT BIG: Behavioral Treatment Programs for Speech and Body Movement in Parkinson Disease. Parkinsons Dis. , 2012, 391946. https://doi:10.1155/2012/391946.
8. Goldman, J. G., Volpe, D., Ellis, T. D., Hirsch, M. A., Johnson, J., Wood, J., Aragon, A., Biundo, R., Di Rocco, A., Kasman, G. S., Iansek, R., Miyasaki, J., McConvey, V. M., Munneke, M., Pinto, S., St Clair, K. A., Toledo, S., York, M. K., Todaro, R., Yarab, N., & Wallock, K. (2024). Delivering Multidisciplinary Rehabilitation Care in Parkinson's Disease: An International Consensus Statement. Journal of Parkinson's disease, 14(1), 135–166. https://doi.org/10.3233/JPD-230117.
9. Kaddour, A. (2018). La prise en charge de la dysarthrie par la méthode LSVT®. Grin Verlag Munich, ISBN : 9783668646414.
10. Le Huche, F., & Allali, A. (1989). La voix- Tome 4 : thérapeutique des troubles vocaux. Phoniatrie (3ème édition, Vol. Tome 4). Issy Les Moulineaux: Elsevier Masson.
11. Machado Sotomayor, M. J., Arufe-Giráldez, V., Ruíz-Rico, G., & Navarro-Patón, R. (2021). Music Therapy and Parkinson's Disease: A Systematic Review from 2015-2020. *International journal of environmental research and public health, 18(21), 11618. https://doi.org/10.3390/ijerph182111618.
12. Ma, A., Lau, K. K., & Thyagarajan, D. (2020). Voice changes in Parkinson's disease: What are they telling us?. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia, 72, 1–7. https://doi.org/10.1016/j.jocn.2019.12.029.
13. Pinto, S., Cardoso, R., Atkinson-Clement, C., Guimarães, I., Sadat, J., Santos, H., Mercier, C., Carvalho, J., Cuartero, M. C., Oliveira, P., Welby, P., Frota, S., Cavazzini, E., Vigário, M., Letanneux, A., Cruz, M., Brulefert, C., Desmoulins, M., Martins, I. P., Rothe-Neves, R., & Ferreira, J. J. (2024). Do Acoustic Characteristics of Dysarthria in People With Parkinson's Disease Differ Across Languages?. Journal of speech, language, and hearing research: JSLHR, 67(9), 2822–2841. https://doi.org/10.1044/2024_JSLHR-23-00525.
14. Ramig, L., Halpern, A., Spielman, J., Fox, C., & Freeman, K. (2018). Speech treatment in Parkinson's disease: Randomized controlled trial (RCT). Movement disorders: official journal of the Movement Disorder Society, 33(11), 1777–1791. https://doi.org/10.1002/mds.27460.
15. Radhakrishnan, N. N.(2022). Nasal Resistance (NR) Technique: A Novel Approach to Improve Glottal Adduction. J Voice, 36(1), 91-97. https://doi:10.1016/j.jvoice.2020.04.020.
16. Selikhova, M., Tripoliti, E., Fedoryshyn, L., Matvienko, Y., Stanetska, H., Boychuk, M., Komnatska, I., Lees, A. J., & Sanotsky, Y. (2016). Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse. Clinical neurology and neurosurgery, 147, 71–77. https://doi.org/10.1016/j.clineuro.2016.05.027.
17. Simon, D. K., Tanner, C. M., & Brundin, P. (2020). Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in geriatric medicine, 36(1), 1–12. https://doi.org/10.1016/j.cger.2019.08.002.
18. Spielman, J., Mahler, L., Halpern, A., Gilley, P., Klepitskaya, O., & Ramig, L. (2011). Intensive voice treatment (LSVT®LOUD) for Parkinson’s disease following deep brain stimulation of the subthalamic nucleus. Journal of Communication Disorders, 44(6), 688–700.
19. Theodoros, D., & Anderson, A. (2024). Speech therapy for people with Parkinson's disease. BMJ (Clinical research ed.), 386, q1254. https://doi.org/10.1136/bmj.q1254.
20. Pinto, S., Ozsancak, C., Tripoliti, E., Thobois, S., Limousin-Dowsey, P., & Auzou, P. (2004). Treatments for dysarthria in Parkinson's disease. The Lancet. Neurology, 3(9), 547–556. https://doi.org/10.1016/S1474-4422(04)00854-3.